Roland Fenk

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Journal: Nature medicine

Published: July 06, 2026

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 08, 2026

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 21, 2026

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

Journal: Nature medicine

Published: September 26, 2025

Prospective systematic classification of causes of death in the course of multiple myeloma.

Prospective systematic classification of causes of death in the course of multiple myeloma.

Journal: Blood cancer journal

Published: July 02, 2025

Evaluation of a screening algorithm to detect cardiac amyloidosis in mild to severe aortic valve stenosis.

Evaluation of a screening algorithm to detect cardiac amyloidosis in mild to severe aortic valve stenosis.

Journal: Cardio-oncology (London, England)

Published: May 04, 2025

Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell Disorders.

Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell Disorders.

Journal: Academic radiology

Published: March 21, 2025

Tracking reduction-induced molecular changes in pathological free light chains by SV-AUC.

Tracking reduction-induced molecular changes in pathological free light chains by SV-AUC.

Journal: European biophysics journal : EBJ

Published: December 20, 2024

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 09, 2024

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.

Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2024

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Journal: Blood cancer discovery

Published: November 25, 2024

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial.

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial.

Journal: Blood

Published: October 17, 2024

Showing 1-12 of 73

Last Updated: 09/26/2026